9552 — M&A Research Institute Holdings Income Statement
0.000.00%
- ¥218bn
- ¥208bn
- ¥9bn
- 69
- 10
- 35
- 28
Annual income statement for M&A Research Institute Holdings, fiscal year end - September 30th, JPY millions except per share, conversion factor applied.
2020 September 30th | 2021 September 30th | 2022 September 30th | 2023 September 30th | |
---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | Yuho | Yuho |
Standards: | JAS | JAS | JAS | JAS |
Status: | Final | Final | Final | Final |
Revenue | ||||
Total Revenue | 376 | 1,328 | 3,912 | 8,643 |
Cost of Revenue | ||||
Gross Profit | 262 | 1,039 | 3,123 | 6,617 |
Selling / General / Administrative Expenses | ||||
Research And Development | ||||
Depreciation and Amortization | ||||
Unusual Expense / Income | ||||
Other Operating Expenses | ||||
Total Operating Expenses | 373 | 765 | 1,808 | 4,156 |
Operating Profit | 3.29 | 563 | 2,104 | 4,486 |
Gain / Loss on Sale of Assets | ||||
Total Net Non Operating Interest Income / Expense | ||||
Other Net Non Operating Costs | ||||
Net Income Before Taxes | 3.91 | 558 | 2,083 | 4,485 |
Provision for Income Taxes | ||||
Net Income After Taxes | 4.25 | 368 | 1,327 | 2,647 |
Net Income Before Extraordinary Items | ||||
Net Income | 4.25 | 368 | 1,327 | 2,647 |
Adjustments to Net Income | ||||
Income Available to Common Shareholders Excluding Extraordinary Items | ||||
Income Available to Common Shareholders Including Extraordinary Items | ||||
Diluted Net Income | 4.25 | 368 | 1,327 | 2,647 |
Diluted Weighted Average Shares | ||||
Basic EPS Including Extraordinary Items | ||||
Diluted EPS Including Extraordinary Items | ||||
Diluted EPS Excluding Extraordinary Items | ||||
Normalised Income Before Taxes | ||||
Normalised Income After Taxes | ||||
Normalised Income Available to Common Shareholders | ||||
Diluted Normalised EPS | 0.077 | 6.62 | 21.5 | 42.1 |
Dividends per Share |